NCT05949814Completed
EASY-TESTS: Evaluation of the Acceptability of Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex With Men (MSM) Who Accepted Targeted HIV/STI Testing, Recruited Through a Community-based Outreach Approach, Both Digital and In-person.
Source: ClinicalTrials.gov · Last updated 4 Sept 2025
Brief summary (registry, in English)
Acceptability of a PrEP program among MSM and TG visiting a geolocated community application or a community physical place of sociability and having accepted a targeted screening for HIV, Hepatitis B, C and STIs.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 209 (actual)
- First submitted
- 10 Jul 2023
- Start date
- 30 Jul 2023
- Primary completion date
- 15 Apr 2025
- Lead sponsor
- Centre de santé sexuelle Le 190
- Diseases
- HIV
- NCT number
- NCT05949814
What you commit to
- Study type: Observational
- Participants enrolled: 209
- From 30 Jul 2023 to the primary completion date, 15 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Planned stay in France \<1 month
- Person under legal guardianship
Who the study is looking for
- Cisgender men, transgender men, and transgender women reporting sexual relations with men
- Age 18 years old
- Accepting an STIs screening after contact through a geolocated community application or a physical place of community sociability
- Given oral non-opposition to the anonymized use of the collected data
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Le SPOT Coordinator of this site? Confirm its status | Paris | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.